Skip to main content

Peer Review reports

From: A real-world pharmacovigilance study of netarsudil based on the FDA adverse event reporting system (FAERS)

Original Submission
17 Feb 2025 Submitted Original manuscript
2 Mar 2025 Reviewed Reviewer Report
5 Mar 2025 Reviewed Reviewer Report
21 Mar 2025 Author responded Author comments - Taomin Huang
Resubmission - Version 2
21 Mar 2025 Submitted Manuscript version 2
2 Apr 2025 Reviewed Reviewer Report
2 Apr 2025 Reviewed Reviewer Report
11 Apr 2025 Author responded Author comments - Taomin Huang
Resubmission - Version 3
11 Apr 2025 Submitted Manuscript version 3
13 Apr 2025 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
15 Apr 2025 Editorially accepted
21 Apr 2025 Article published 10.1186/s40360-025-00927-x

You can find further information about peer review here.

Back to article page